Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Clinical trial NCT03973333 · WITHDRAWN

Trial details

NCT number: NCT03973333
Sponsor: Immunocore Ltd
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Select Advanced Solid Tumors

Start date: 2019-05-17
Primary completion: 2023-09-25
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.